iHealthScreen cleared a crucial FDA hurdle, but can iPredict-DR break AI eye screening’s adoption barrier?
iHealthScreen’s FDA-cleared iPredict-DR brings automated diabetic retinopathy screening closer to primary care, but adoption hurdles remain.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
Natera just cleared a major European hurdle for Signatera, but can hospitals turn certification into adoption?
Natera’s Signatera gains European IVDR certification across multiple cancers, opening a new phase for personalized MRD testing and clinical adoption.
Medical Devices & Diagnostics
KKR is quietly building a medtech manufacturing powerhouse around Precipart
KKR is building Allyntra around Precipart to expand precision engineering and medical device manufacturing. See what the strategy means.
Medical Devices & Diagnostics
Bausch + Lomb is moving beyond eye-care products with an AI platform built around the patient journey
Bausch + Lomb’s Orphia brings AI to cataract education, but adoption will depend on workflow integration, validation, privacy and trust.
Medical Devices & Diagnostics
How the NeoGenomics PTEN IHC test supports targeted prostate cancer treatment
NeoGenomics launches an FDA-approved PTEN IHC companion diagnostic to identify prostate cancer patients eligible for AstraZeneca’s Truqap.
Medical Devices & Diagnostics
Resmed agrees $490m MatrixCare sale to Frazier Healthcare Partners
ResMed Inc. has agreed to sell its MatrixCare healthcare software business to Frazier Healthcare Partners for $490 million in cash, reversing part of a diversification strategy that began when the medical-device company acquired MatrixCare for $750 million in 2018. The transaction is expected to close during the first quarter of Resmed’s fiscal year 2027, subject
Medical Devices & Diagnostics
Elucid AI-PREDICT study begins testing lesion-level heart attack risk with CCTA
Elucid’s AI-PREDICT study will test whether CCTA plaque analysis can identify the coronary lesions most likely to cause a heart attack.
Medical Devices & Diagnostics
Could this 30-second ear test become urgent care’s next profitable diagnostic standard?
Intellivisit data suggest tympanometry could improve urgent care ear assessments while reaching financial break-even within about one month.
Medical Devices & Diagnostics
Steel Partners challenges InMode insider buyout with $16.75-a-share cash offer
Steel Partners Holdings L.P. has offered to acquire InMode Ltd. for $16.75 per share in cash, escalating a takeover contest surrounding the Israeli medical aesthetics company and placing additional pressure on its independent directors to determine whether shareholders are being offered sufficient value. InMode confirmed on July 10, 2026 that its board had received the
Medical Devices & Diagnostics
Stereotaxis completes Robocath acquisition to expand endovascular robotics platform
Stereotaxis, Inc. has completed its acquisition of French vascular robotics developer Robocath, bringing together two different approaches to controlling medical devices during minimally invasive endovascular procedures. Robocath will be integrated into the United States-based surgical robotics company, which plans to combine its magnetic navigation technology with Robocath’s mechanically controlled platforms for interventional cardiology, neurointerventions and